These findings indicate that IL-6-mediated activation of the MAPK/ERK signalling pathway plays a crucial role in enhancing tumour cell migration, invasion, and radioresistance in HNSCC. This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.